Skip to main content

Ranibizumab and bevacizumab for AMD.

Publication ,  Journal Article
Cheung, CMG; Wong, TY
Published in: N Engl J Med
December 8, 2011

Duke Scholars

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

December 8, 2011

Volume

365

Issue

23

Start / End Page

2237

Location

United States

Related Subject Headings

  • Male
  • Macular Degeneration
  • Humans
  • General & Internal Medicine
  • Female
  • Antibodies, Monoclonal
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cheung, C. M. G., & Wong, T. Y. (2011). Ranibizumab and bevacizumab for AMD. N Engl J Med, 365(23), 2237. https://doi.org/10.1056/NEJMc1107895
Cheung, CM Gemmy, and Tien Y. Wong. “Ranibizumab and bevacizumab for AMD.N Engl J Med 365, no. 23 (December 8, 2011): 2237. https://doi.org/10.1056/NEJMc1107895.
Cheung CMG, Wong TY. Ranibizumab and bevacizumab for AMD. N Engl J Med. 2011 Dec 8;365(23):2237.
Cheung, CM Gemmy, and Tien Y. Wong. “Ranibizumab and bevacizumab for AMD.N Engl J Med, vol. 365, no. 23, Dec. 2011, p. 2237. Pubmed, doi:10.1056/NEJMc1107895.
Cheung CMG, Wong TY. Ranibizumab and bevacizumab for AMD. N Engl J Med. 2011 Dec 8;365(23):2237.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

December 8, 2011

Volume

365

Issue

23

Start / End Page

2237

Location

United States

Related Subject Headings

  • Male
  • Macular Degeneration
  • Humans
  • General & Internal Medicine
  • Female
  • Antibodies, Monoclonal
  • 42 Health sciences
  • 32 Biomedical and clinical sciences
  • 11 Medical and Health Sciences